The Cooper Companies, Inc. (NASDAQ:COO) Stock Holdings Lessened by Russell Investments Group Ltd.

Russell Investments Group Ltd. trimmed its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 20.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 399,690 shares of the medical device company’s stock after selling 104,235 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.20% of Cooper Companies worth $36,736,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the stock. Captrust Financial Advisors lifted its position in shares of Cooper Companies by 9.7% in the 3rd quarter. Captrust Financial Advisors now owns 3,816 shares of the medical device company’s stock valued at $421,000 after acquiring an additional 338 shares in the last quarter. HighTower Advisors LLC grew its holdings in shares of Cooper Companies by 11.7% during the third quarter. HighTower Advisors LLC now owns 20,506 shares of the medical device company’s stock valued at $2,261,000 after buying an additional 2,155 shares in the last quarter. Stifel Financial Corp raised its position in Cooper Companies by 1.2% during the third quarter. Stifel Financial Corp now owns 231,806 shares of the medical device company’s stock valued at $25,578,000 after buying an additional 2,670 shares during the period. MML Investors Services LLC lifted its stake in Cooper Companies by 1.6% in the 3rd quarter. MML Investors Services LLC now owns 17,787 shares of the medical device company’s stock worth $1,963,000 after acquiring an additional 280 shares in the last quarter. Finally, Nomura Asset Management Co. Ltd. grew its stake in Cooper Companies by 8.1% during the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 58,703 shares of the medical device company’s stock valued at $6,477,000 after acquiring an additional 4,408 shares in the last quarter. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on COO shares. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research report on Friday, March 7th. Citigroup cut their target price on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a research report on Friday, March 7th. BNP Paribas upgraded shares of Cooper Companies to a “hold” rating in a report on Thursday, March 13th. JPMorgan Chase & Co. cut their price objective on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating for the company in a report on Friday, March 7th. Finally, StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $110.25.

Cooper Companies Stock Down 0.6 %

Shares of COO stock opened at $73.31 on Tuesday. The stock’s 50 day simple moving average is $87.24 and its 200 day simple moving average is $95.87. The Cooper Companies, Inc. has a twelve month low of $70.80 and a twelve month high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The company has a market capitalization of $14.66 billion, a price-to-earnings ratio of 37.60, a PEG ratio of 2.25 and a beta of 1.01.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.92. The business had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. As a group, research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.